NPLEx (National Precursor Log Exchange)

Browse NPLEx (National Precursor Log Exchange) Content

On Tuesday, April 13, the Oregon House Committee on Health Care voted unanimously to advance H.B. 2648 to the full House of Representatives for a vote.

Apr 14, 2021

On Wednesday, March 17, Mississippi Governor Tate Reeves signed S.B. 2119, repealing a law that overturns the state’s ban of over-the-counter (OTC) sales of pseudoephedrine (PSE).

Mar 18, 2021

The new law returns PSE to OTC status allowing consumers to purchase 3.6 grams of PSE per day, up to 7.2 grams per month.

Mar 17, 2021

In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).

Mar 17, 2021

On Tuesday, March 9, the Mississippi House voted to repeal the state’s existing ban of over-the-counter (OTC) sales of pseudoephedrine (PSE) on an 117-3 vote. Since 2010, Mississippi has categorized PSE as a schedule III controlled substance.

Mar 10, 2021

CHPA applauds the state of Georgia for becoming the thirty-third state to adopt the real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx).

Apr 28, 2016

So far, 31 states have adopted real-time, stop-sale technology. The blocking technology monitors all nonprescription PSE purchases in real-time to prevent meth criminals from exceeding legal limits.

Mar 31, 2014

CHPA is committed to advancing solutions to illegal sales that penalize criminals and ensure law-abiding consumers continue to have access to a wide range of treatment options, including nonprescription medicines containing PSE.

Filter Results